跳至主要内容
临床试验/CTRI/2019/01/017359
CTRI/2019/01/017359尚未招募3 期

A Comparative Study to Evaluate Effectiveness of "Pathya Counselling"in Management of "Amavata (Rheumatoid Arthritis)"

Chaudhary Brahm Prakash Ayurved Charak Sansthan1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2019年1月2日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
Reduction in DAS-28 score

研究概览

简要总结

Amavata is vata kapha dominant tridhoshaj disease caused mainly due to viruddhara (incompatible diet) and mandagni (low digestive fire). Viruddhara and mandagni  leads to formation of Apakwa rasa(partially digested rasa dhatu); manifesting as Ama. Rheumatoid arthritis (RA) is a chronic inflammatory disease of unknown etiology marked by a symmetric, peripheral polyarthritis. It is the most common form of chronic inflammatory arthritis and often results in joint damage and physical disability.RA affects approximately 0.5-1% of the adult population worldwide and about 0.1-0.4% Indian population. The treatment in RA comprises the early use of disease-modifying antirheumatic drugs DMARDs and corticosteroids for induction of remission. These drugs have serious side effects like GI upset, nausea, stomatitis, rash, alopecia, hepatotoxicity, acute pneumonitis, renal impairment, hypertension, osteoporosis, etc. The term “Pathya†is derived from the term –“Patha†(which means “srotasâ€or bodily minute channels). Pathya(wholesome) refers to the diet and regimen which is conducive to the bodily channels and is pleasant to  mind. Hence, it is widely accepted by the patient’s body and the patient himself. Pathya is an important adjuvant with drugs in Ayurvedic management of disease.Though, Pathya is not a substitute of medicine, it changes the landscape of the disease as an addition to commonly prescribed Ayurvedic medications.In every consultation, an Ayurvedic doctor pays heed in explaining the wholesome and unwholesome diet and lifestyle regime to the patient along with the medications. Patients are also concerned about appropriate diet; since Pathya Counselling is equally important and give promising results when combined with therapeutic drugs as to be done in this study. As there is scarcity of reliable scientific study on effectiveness of Pathya Counselling in management of Amavata (Rheumatoid arthritis), present study has been planned to observe, collect, collate, and analyze the effects of Pathya Counselling in patients of Amavata.

Aim of the study is to evaluate effectiveness of “Pathya Counselling†in management of “Amavata (Rheumatoid arthritis)â€. Primary Objective is to offer “Pathya Counselling†training along with commonly prescribed Ayurvedic treatment in patients of Amavata (Rheumatoid arthritis). Secondary Objective is to evaluate the effect of “Pathya Counselling†in management of Amavata. Type of study is Interventional. Study Design is Randomized Clinical Trial. Study setting is Single centered (O.P.D. / I.P.D. in Ch. Brahm Prakash Ayurved Charak Sansthan, Khera Dabar, New Delhi). Duration of trial is 7 weeks (49 Days). Enrolled patients in Group-A and Group-B will be examined for a 7 day follow-up after completion of intervention at Day 42.

Sample size is 30 patients.  Individuals presenting with either clinical features of Rheumatoid arthritis described in modern medical literature or the clinical features of Amavata described in Madhava Nidana will be selected for sampling. Inclusion criteria involves 1. Patients having the clinical features of Amavata as described in Madhav Nidana  2. Patients fulfilling the 2010 ACR-EULAR criteria for Rheumatoid arthritis and so on. Exclusion Criteria involves Concomitant any other treatment (DMARDs, glucocorticoids etc) other than commonly prescribed Ayurvedic treatment of Amavata 2. Patients with crippling bone deformities 3. Seriously ill and moribund patients and so on. Adult subjects fulfilling the inclusion criteria and devoid of any of the exclusion criteria will be randomized as per simple randomization plan in two groups. GROUP-A (Trial group)- Pathya Counselling provided along with commonly prescribed Ayurvedic treatment of Amavata.

GROUP-B (Comparator group)- No Pathya Counselling provided along with commonly prescribed Ayurvedic treatment of Amavata..Assessment criteria involves Primary criteria is DAS-28 score. Secondary criteria is 1.Status of Dhatu Samyata and Vikaropshama (Charak Samhita) 2. Amavata symptom severity scale 3. Visual Analogue Scale (VAS) and Erythrocyte Sedimentation Rate (ESR). DAS-28 will be assessed on Day 1, 42 and 49. Status of Dhatu Samyata and Vikaropshama and Amavata symptom severity scale assessed on Day 1, 7,14, 21, 28, 35,42 and 49. VAS and ESR on Day 1, 42 and 49. Outcome Measures involves Primary outcome measure is Reduction in DAS-28 score. Secondary outcome measures are 1. Attainment of status of Dhatu Samayata and Vikaropsama. 2. Reduction in Amavata symptom severity scale. 3. Reduction in Visual Analogue Scale (VAS) and Erythrocyte Sedimentation Rate (ESR).  Level of improvement for outcome measures - DAS28 and ESR will be decided as poor, fair, good, very good and excellent relief. Reduction in Amavata symptom severity scale on the basis of five (5) item – four (4) point scale.  Attainment of Dhatu Samyata and Vikaropsama will be assessed on the basis of twelve (12) item-three (3) point scale. Patient’s data with three different levels of adherence to Pathya will be recorded as poor, good and excellent adherance depending on the number of violations of Pathya( wholesome and unwholesome diet and lifestyle regime) in a week.

研究设计

研究类型
Interventional

入排标准

年龄范围
21.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients having the clinical features of Amavata as described in Madhav Nidana Patients fulfilling the 2010 ACR-EULAR criteria for Rheumatoid arthritis Patients who are only on commonly prescribed Ayurvedic treatment of Amavata Patients not following any dietary restrictions from past 6 months Age 21 to 60 years Sex both sexes Patients suffering from disease for less than 3yrs Patients who are ready to give consent for trial Patients with firm home address and contact no which is readily accessible during course of trial.

排除标准

  • Concomitant any other treatment (DMARDs glucocorticoids etc) other than commonly prescribed Ayurvedic treatment of Amavata Patients with crippling bone deformities Seriously ill and moribund patients Abnormal renal or hepatic functions malignancy hypertension cardiovascular disorder HIV-AIDS etc Patients planning to conceive in near future (during course of trial) Pregnant and lactating mothers Any major psychiatric illness Any other pre-existing illness that will require surgery during course of trial Patients with any other concomitant Arthropathy like Ankylosing Spondylosis Osteomyelitis Gouty Arthritis Neoplasm of spine Fractures etc.

结局指标

主要结局

Reduction in DAS-28 score

时间窗: Day1 Day42 Day49

次要结局

  • Attainment of status of Dhatu Samayata and Vikaropsama(Reduction in Amavata symptom severity scale)
  • Reduction in Visual Analogue Scale (VAS) and Erythrocyte Sedimentation Rate (ESR)(Day1 Day42 Day49)

研究者

发起方
Chaudhary Brahm Prakash Ayurved Charak Sansthan
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验

To Check the Comparative Effectiveness of "Wholesome... | 临床试验